BSE - Delayed Quote INR

Abbott India Limited (ABBOTINDIA.BO)

Compare
29,946.35
+6.75
+(0.02%)
At close: 3:29:39 PM GMT+5:30
Loading Chart for ABBOTINDIA.BO
DELL
  • Previous Close 29,939.60
  • Open 30,089.45
  • Bid 29,950.00 x --
  • Ask 30,550.00 x --
  • Day's Range 29,908.00 - 30,683.40
  • 52 Week Range 22,948.30 - 30,683.40
  • Volume 1,172
  • Avg. Volume 325
  • Market Cap (intraday) 636.339B
  • Beta (5Y Monthly) 0.01
  • PE Ratio (TTM) 49.52
  • EPS (TTM) 604.78
  • Earnings Date Jan 30, 2025 - Feb 3, 2025
  • Forward Dividend & Yield 410.00 (1.37%)
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est 28,331.43

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

www.abbott.co.in

3,814

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ABBOTINDIA.BO

View More

Performance Overview: ABBOTINDIA.BO

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ABBOTINDIA.BO
0.52%
S&P BSE SENSEX
0.06%

1-Year Return

ABBOTINDIA.BO
27.33%
S&P BSE SENSEX
8.57%

3-Year Return

ABBOTINDIA.BO
66.64%
S&P BSE SENSEX
31.20%

5-Year Return

ABBOTINDIA.BO
151.89%
S&P BSE SENSEX
92.25%

Compare To: ABBOTINDIA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ABBOTINDIA.BO

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    636.20B

  • Enterprise Value

    617.94B

  • Trailing P/E

    49.52

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.49

  • Price/Book (mrq)

    18.07

  • Enterprise Value/Revenue

    10.19

  • Enterprise Value/EBITDA

    34.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.18%

  • Return on Assets (ttm)

    19.22%

  • Return on Equity (ttm)

    38.75%

  • Revenue (ttm)

    60.66B

  • Net Income Avi to Common (ttm)

    12.85B

  • Diluted EPS (ttm)

    604.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.06B

  • Total Debt/Equity (mrq)

    1.72%

  • Levered Free Cash Flow (ttm)

    1.11B

Research Analysis: ABBOTINDIA.BO

View More

People Also Watch